Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.

Bartolome R CelliJulie A AndersonRobert BrookPeter CalverleyNicholas J CowansCourtney CrimIan DixonVictor KimFernando J MartinezAndrea MorrisDavid E NewbyJulie YatesJoergen Vestbo

Published in: BMJ open respiratory research (2019)

NCT01313676.

Keyphrases

clinical trial
study protocol
open label
phase iii
phase ii
chronic obstructive pulmonary disease
double blind
lung function
placebo controlled
randomized controlled trial
high intensity
metabolic syndrome
cystic fibrosis
adipose tissue